Today the development of a single drug can take up to 15 years and cost over USD 1 billion. This creates an urgent need to expedite drug benefits to patients in a safe and cost-effective manner. The extensive process to take a drug from bench-to-bedside is currently driven by paper-based processes, causing redundant efforts, disconnected stakeholders, and regulatory burdens. IT can shorten the time span, streamlining processes and collaboration and lowering the overall cost of the clinical drug development lifecycle.
Rays has several years of experience in providing application development consultancy services related to Clinical research in the areas of Protocol and IND Management, Adverse Event Expedited Reporting, Site Audit Scheduling and Management, Regulatory Support, and much more. Rays has developed eProtocol - a Protocol Authoring, Review and Commenting Tool to enable the authoring and approval of a study.